AI MARKET SCANNING

Halozyme Therapeutics, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +3.47%
MAX GAP RECORD +10.07%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $HALO
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
+4.94%
May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE)
+5.57%
Feb 17, 2026 Earnings Release 2026-02-17 (AFTER CLOSE)
-3.53%
Nov 03, 2025 Earnings Release 2025-11-03 (AFTER CLOSE)
+2.18%
Aug 05, 2025 Earnings Release 2025-08-05 (AFTER CLOSE)
+3.68%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
+7.26%
Feb 18, 2025 Earnings Release 2025-02-18 (AFTER CLOSE)
+1.87%
Oct 31, 2024 Earnings Release 2024-10-31 (AFTER CLOSE)
+10.07%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.4%
Bullish Gaps (12)
Bearish Gaps (3)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $HALO

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-29 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 2707m +5.90%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗